Barden Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,004
Closed -$933K 68
2023
Q4
$933K Buy
+9,004
New +$935K 0.76% 51
2023
Q2
Sell
-6,160
Closed -$655K 69
2023
Q1
$655K Buy
+6,160
New +$665K 0.63% 59

Other funds holding MRK

Barden Capital Management's MRK Position: Q1 2024 in Review

Barden Capital Management sold out of Merck (MRK) in Q1 2024, closing a stake of 9,004 shares — an estimated $933K sold.

Barden Capital Management first reported a position in MRK in Q1 2023 and held it in 2 quarters. The position peaked at $933K in Q4 2023. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Barden Capital Management reported no remaining Merck position as of Q1 2024 after selling out during the quarter.
  • Barden Capital Management sold 9,004 Merck shares in Q1 2024, an estimated $933K.
  • Barden Capital Management first reported a position in Merck in Q1 2023 and held it in 2 quarters.
  • Barden Capital Management's Merck position peaked at $933K in Q4 2023.
  • 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Barden Capital Management's 13F filing for Q1 2024, filed 9 May 2024.